LDHA and neoplasm: The elevated ALDH expression in CSCs is verified to induce tumor progression, metastasis, treatment resistance, and immune evasion [54,55,56], underscoring ALDHs as a remarkable CSC biomarker, notably in lung cancer [41,57].